🔗 Visit the ClinicalTrials.gov page for NCT00720174
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 2 | Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations. | Sarcoma | 2011 | 0.98 |
| 3 | Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. | Stem Cells Int | 2016 | 0.81 |
| 4 | Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives. | Oncol Rev | 2013 | 0.79 |
| 5 | Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model. | Ann Oncol | 2015 | 0.78 |
| 6 | Immune-based therapeutics for pediatric cancer. | Expert Opin Biol Ther | 2010 | 0.78 |
| 7 | Targeting angiogenesis in childhood sarcomas. | Sarcoma | 2010 | 0.77 |